STOCKWATCH
·
Pharmaceuticals
Quarterly Result12 Aug 2025, 01:29 pm

Alkem Laboratories Ltd Announces Q1 2025 Financial Results with 33,711.4 Million Revenue

AI Summary

Alkem Laboratories Ltd has announced its financial results for the quarter ended 30 June, 2025. The company reported a revenue from operations of 33,711.4 million and total income of 35,076.3 million. The expenses for the quarter stood at 7,770.3 million, leading to a net profit of 6,699.9 million. The company's total comprehensive income for the quarter was 22,351.0 million.

Key Highlights

  • Revenue from operations stands at 33,711.4 million
  • Total income reported is 35,076.3 million
  • Expenses for the quarter are 7,770.3 million
  • Net profit for the quarter is 6,699.9 million
  • Total comprehensive income for the quarter is 22,351.0 million
ALKEM
Pharmaceuticals
Alkem Laboratories Ltd

Price Impact